1. www.womenshealth.gov/FAQ/pregnancy-tests.cfm#d
2. http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_04.pdf
3. www.acog.org/acog_districts/dist1jf/teachingmoduleearlypregnancyissues.ppt—2009-02-05
4. Induced Abortion. ACOG Patient Education Pamphlet, June 2007
5. Rock J, Thompson J. TeLinde’s Operative Gynecology, 8th edition, Lippincott-Raven, 1997.
6. Induced Abortion. ACOG.
7. Rock J, Thompson J. TeLinde’s Operative Gynecology
8. Stenchever M, Comprehensive Gynecology, 4th Edition, Mosby, Inc., 2001
9. www.fatherlovesourcity.com/…/introduction.html
10. Alan Gutmacher Institute
11. Focus on the Family
12. In Our Midst Ministries
13. Mifeprex (mifepristone) Information. Center for Drug Evaluation and Research, US Food and Drug Administration, http://www.fda.gov/cder/drug/infopage/mifepristone/ (accessed June 16, 2008)
14. Mifeprex Package Insert, July 2005
15. Gary M. Harrison D. Analysis of severe adverse events related to the use of Mifepristone as an abortifacient. The Annals of Pharmacology 2006; 40.
16. Medial Management of Abortion. ACOG Practice Bulletin No. 67 American College of Obstetricians and Gynecologists October 2005.
17. Study by Dr. Vincent Rue, clinical psychologist; Dr David Reardon of Elliot Institute; and Priscilla Colemen, researcher at Bowling Green State University. Reported by LifeNews.com 12-1-04.
18.
19. Katz V, et al. Comprehensive Gynecology, 5th edition, Mosby-Elsevier, 2007.
20. Rock J, Thompson J. TeLinde’s Operative Gynecology, 8th edition, Lippincott-Raven, 1997.
21. Stenchever M, Comprehensive Gynecology, 4th Edition, Mosby, Inc., 2001
22. Mifeprex Package Insert, July 2005
23. Katz V, et al. Comprehensive Gynecology, 5th edition, Mosby-Elsevier, 2007.
24. Stenchever M, Comprehensive Gynecology, 4th Edition, Mosby, Inc., 2001
25. Antibiotic Prohyllaxis for Gynecologic Procedures. ACOG Practice Bulletin no. 74, July 2006
26. Dilatation and Curettage. ACOG Patient Education Bulletin. December 2005
27. Medical Management of Abortion. ACOG.
28. Katz V, et al. Comprehensive Gynecology, 5th edition, Mosby-Elsevier, 2007.
29. Rock J, Thompson J. TeLinde’s Operative Gynecology, 8th edition, Lippincott-Raven, 1997.
30. Ibid.
31. Ibid.
32. Ibid.
33. Katz V, et al. Comprehensive Gynecology, 5th edition, Mosby-Elsevier, 2007.
34. Rooney B, Calhoun B. Induced Abortion and risk of later premature births. Journal of American Physicians and Surgeons 2003
35. Ancel P, et al. History of induced abortion as a risk factor for preterm birth in European countries: results of the EUROPOP survey. Human Reproduction 2004.
36. Behrman R, Stith B. Preterm Birth: Causes, consequences, and prevention. Institute of Medicine of the National Academy of Science, 2006.
37. Russo J, et al. Developmental, molecular and cellular basis of human breast cancer. Journal of National Cancer Institute. Monograph 2000
38. Russo J, et al. Caner risk related to mammary gland structure and development. Microscopy Research and Technique 2000.
39. Melbye M, et al. Preterm delivery and risk of breast cancer. British Journal of Cancer 1999.
40. Hsieh c, et al. Delivery of premature newborns and maternal breast-cancer risk. Lancet 1999
41. MacMahon, et al. Age at any birth and breast cancer risk. Bulletin of the World Health Organization 1970
42.
43. Brind J. Induced abortion as an independent risk factor for breast cancer; a comprehensive review and meta-analysis. Journal of Epidemiology and Community Health 1996
44. Daling J, et al. Risk of breast cancer among young women: relationship to induced abortion. Journal of the National Cancer Institute 1994.
45. Carroll P. The breast cancer epidemic: modeling and forecasts based on abortion and other risk factors. Journal of American Physicians and Surgeons 2007.
46. Howe, et al. Induced abortion and breast cancer. International Journal of Epidemiology 1989
47. Thorp JM, Shadigian E, et al. Long-term physical and psychological health consequences of induced abortion: review of the evidence. Obstetrical & Gynecological Survey 2003.